Caitlyn A. Chapman

ORCID: 0000-0001-7391-0011
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Electrospun Nanofibers in Biomedical Applications
  • Conducting polymers and applications
  • Advanced Sensor and Energy Harvesting Materials
  • Neuroscience and Neural Engineering
  • Nerve injury and regeneration
  • Neuroscience and Neuropharmacology Research
  • Neural dynamics and brain function
  • Supercapacitor Materials and Fabrication
  • Therapeutic Uses of Natural Elements
  • Tissue Engineering and Regenerative Medicine
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Memory and Neural Mechanisms
  • Iron oxide chemistry and applications
  • Clay minerals and soil interactions
  • Graphene and Nanomaterials Applications

University of Pittsburgh
2022-2023

Rensselaer Polytechnic Institute
2018-2021

High-performance cellulose–halloysite hemostatic nanocomposite fibers (CHNFs) are fabricated using a one-step wet–wet electrospinning process and evaluated for human plasma coagulation by activated partial thromboplastin time. These novel biocompatible CHNFs exhibit 2.4 times faster time compared with the industry gold standard QuikClot Combat Gauze (QCG). The have superior antileaching property of clay 3 higher post-wetting clotting activity to QCG. also coagulate whole blood 1.3 than QCG...

10.1021/acsami.9b04615 article EN ACS Applied Materials & Interfaces 2019-04-12

Electrospinning is a simple method for producing nanoscale or microscale fibers from wide variety of materials. Intrinsically conductive polymers (ICPs), such as polyaniline (PANI), show higher conductivities with the use secondary dopants like m-cresol. However, due to low volatility most dopants, it has not been possible electrospin doped ICP fibers. In this work, concept doping applied first time electrospun Using novel design rotating drum electrospinning, were efficiently and reliably...

10.1021/acsami.9b21696 article EN ACS Applied Materials & Interfaces 2020-04-10

Benzodiazepine (BZ) drugs treat seizures, anxiety, insomnia, and alcohol withdrawal by potentiating γ2 subunit containing GABA type A receptors (GABA

10.1016/j.nbd.2023.106248 article EN cc-by-nc-nd Neurobiology of Disease 2023-08-01
Coming Soon ...